e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion
M. Botana, D. Valverde, L. de Chiara, V. Leiro, A. Pallarés, C. Represas, I. Pereiro, A. Fernández-Villar (Vigo, Spain)
Source:
Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Session:
Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Session type:
E-Communication Session
Number:
3554
Disease area:
Interstitial lung diseases, Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Botana, D. Valverde, L. de Chiara, V. Leiro, A. Pallarés, C. Represas, I. Pereiro, A. Fernández-Villar (Vigo, Spain). Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion. Eur Respir J 2010; 36: Suppl. 54, 3554
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Pulmonary sarcoidosis
Related content which might interest you:
Prognostic value of promoter hypermethylation of tumor suppressor genes in malignant pleural fluid
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004
Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011
Alteration of p53 and FHIT genes in pleural effusion associated with malignancy
Source: Eur Respir J 2002; 20: Suppl. 38, 2s
Year: 2002
The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in patients with malignant mesothelioma
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008
The value of IL6 in differentiation between malignant and non malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Diagnostic and prognostic significance of survivin levels in malignant pleural effusion
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Diagnostic value of common MAGE RT-PCR in malignant pleural effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 273s
Year: 2002
Diagnostic usefulness of tumour markers in pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Diagnostic usefulness of C reactive protein levels in pleural effusions of malignant and non malignant origin
Source: Eur Respir J 2007; 30: Suppl. 51, 431s
Year: 2007
Can VEGF be used in differential diagnosis of pleural effusions?
Source: Eur Respir J 2007; 30: Suppl. 51, 565s
Year: 2007
Pleural fluid DNA integrity index as a diagnostic marker of malignant pleural effusion
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept